Journal Thoracic Oncology

Abstracts Journal of Thoracic Oncology • Volume 12 Issue S1 January 2017
FIRST NAME
LAST NAME
NATURE OF RELEVANT
FINANCIAL RELATIONSHIP
Sunil Sharma Grants/Research Support Novartis
NAME OF COMPANY(S)
Sunil Sharma Honoraria Novartis Advisory Board
Alice Shaw Consultant
Alice Shaw Consultant
Alice Shaw Grants/Research Support
Alice Shaw Honoraria Novartis, Pfizer, Roche
Alice Shaw Other (explain):
Emily Sheldon-Waniga Full-time/part-time Employee
Yue Shentu Full-time/part-time Employee Merck & Co., Inc.
ARIAD Pharmaceuticals, Inc., Blueprint Medicines, Daiichi Sankyo,
EMD Serono, Ignyta, Novartis, Pfizer, Roche/Genentech, Taiho,
LOXO
Pfizer, Novartis, Genentech/Roche, Ariad, Blueprint, LOXO, KSQ,
Ignyta, Taiho, Daiichi-Sankyo, EMD Serono
ARIAD Pharmaceuticals, Inc., AstraZeneca, Novartis, Pfizer, Roche/
Genentech
Advisory board or board of directors: Pfizer, Novartis, Genentech/
Roche, ARIAD, Blueprint, WXO, KSQ
Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of
Takeda Pharmaceutical Company Limited
Frances Shepard Other (explain): Prognostic and predictive gene signature for early stage NSCLC
Frances Shepherd Consultant
Frances Shepherd Grants/Research Support Boehringer Ingelheim
Frances Shepherd Honoraria
Frances Shepherd Stock Shareholder (directly purchased) Lilly, AstraZeneca
Sherry Shi Consultant Genentech Roche
Tomoko Shibutani Full-time/part-time Employee Daiichi Sankyo Co., Ltd.
Ryota Shiga Full-time/part-time Employee Daiichi Sankyo. Co., Ltd.
Norah Shire Full-time/part-time Employee AstraZeneca
Keith Shults Full-time/part-time Employee IncellDx
Dale Shuster Full-time/part-time Employee Daiichi Sankyo
Dale Shuster Stock Shareholder (directly purchased) Daiichi Sankyo
Lilly, AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim,
Recombio, Synta, Bristol-Myers Squibb, Roche
Lilly, AstraZeneca, Bristol-Myers Squibb, Merck Serono, Roche/
Genentech, Merck/Schering Plough, Boehringer Ingelheim
Yu Shyr Consultant Roche, Janssen, Aduro, Novartis
Alison Sibley Full-time/part-time Employee Myriad Genetic Laboratories, Inc.
Alison Sibley Stock Shareholder (directly purchased) Myriad Genetic Laboratories, Inc.
Christian Sieder Full-time/part-time Employee Novartis
Jonathan Siegel Full-time/part-time Employee Bayer HealthCare Pharmaceuticals Inc
Frangiscos Sifakis Full-time/part-time Employee AstraZeneca
Frangiscos Sifakis Stock Shareholder (directly purchased) AstraZeneca
Alan Sihoe Consultant Medela AG (Baar, Switzerland)
Branimir Sikic Consultant Threshold, Immune Design
Branimir Sikic Grants/Research Support Sanofi, CellDex, Forty Seven, Gilead, Genentech, Novartis
George Simon Grants/Research Support Boeringer Ingelheim, Merck
George Simon Honoraria Genentech, Eli Lilly, Arriad, Celgene
George Simon Speakers Bureau Celgene
Veena Singh Full-time/part-time Employee Biocept
Patsy Skabla Consultant Pinnacle Biologics
Sarah Smalley Full-time/part-time Employee Inivata
Sarah Smalley Full-time/part-time Employee Inivata
Egbert Smit Consultant Eli Lilly, MSD, Boehringer Ingelheim
Paul Smith Full-time/part-time Employee AstraZeneca
Paul Smith Stock Shareholder (directly purchased) AstraZeneca
Patrik Sobocki Consultant Bristol-Myers Squibb
Patrik Sobocki Grants/Research Support Bristol-Myers Squibb
Mark Socinski Grants/Research Support Celgene, Clovis, Eli Lilly and Company, Genentech
Mark Socinski Honoraria Celgene
Copyright © 2016 by the International Association for the Study of Lung Cancer
S853